Abstract:Background and Objective TSPO (translocator protein, 18 kDa) is up-regulated in activated macrophages, and serves as an attractive target for macrophages molecular imaging. Previous studies showed that TSPO radiotracer can visualize arthritis via positron emission tomography (PET). Compared with PET, single photon emission computed tomography (SPECT) has several advantages, such as lower cost and commercial availability. The aim of the present study is to develop the 99mTc-labeled TSPO ligand CB86 as a novel SPECT probe for imaging of rheumatoid arthritis and preliminary evaluating the effectiveness of steroid anti-inflammatory therapy. Methods A novel TSPO ligand CB86 was linked to DTPAA and then labeled with 99mTc to obtain 99mTc-DTPA-CB86. The labeling efficiency, radiochemical purity, and stability were determined in vitro. In vitro cellular uptake, efflux and binding affinity of 99mTc-DTPA-CB86 to TSPO were performed on RAW264.7 macrophage cells. The distribution and SPECT studies were conducted on Freund’s Adjuvant-Induced Left Arthritis in rats after the injection of 99mTc-DTPA-CB86 with or without co-injection of unlabeled DTPA-CB86. Result The radiosynthesis of 99mTc-DTPA-CB86 was completed successfully with the labeling yields and radiochemical purity of 95.86 ± 2.45 % and 97.45 ± 0.69 %, respectively. 99mTc-DTPA-CB86 displayed good stability, which the radiochemical purity was more than > 90%, in the saline or mouse serum at 4 h. It also exhibited high specific TSPO binging in RAW264.7 macrophage cells in vitro. The highest uptake ratio was (36.45 ± 2.18) % at 3 h after incubation, and decreased significantly after adding excessive unlabeled DTPA-CB86. 99mTc-DTPA-CB86 bound to TSPO with low nanomolar affinity (IC50 =0.49 nM) in RAW264.7 cells. The cell efflux study showed that 99mTc-DTPA-CB86 has good cell retention by RAW264.7 cells, with only about 13.99 % (decreased from (33.31 ± 2.34) % to (19.32 ± 2.01) % of total input radioactivity) of 99mTc-DTPA-CB86 efflux observed during 4.5 h to 8 h incubation. Biodistribution studies showed the left inflammatory ankle uptake was 2.35±0.10 %ID/g, and the inflammatory ankle to muscle ratio was 3.01 ± 0.09 at 180 min after injection. Small animal SPET imaging studies revealed that 99mTc-DTPA-CB86 could clearly identify left inflammatory ankle with good contrast at 30-180 min after injection. Uptake of 99mTc-DTPA-CB86 in the inflammatory ankles could be largely blocked by an excess of unlabled DTPA-CB86. Furthermore, 99mTc-DTPA-CB86 accumulation in the left inflammatory ankles significantly decreased in RA rats treated with dexamethasone. Conclusion 99mTc-DTPA-CB86 can be readily synthesized, clearly visualized arthritis with low background and monitor therapy response of anti-inflammatory therapy, suggesting its potential as a novel promising molecular probe targeting TSPO for arthritic SPECT imaging. Key words TSPO (translocator protein, 18 kDa); Technetium radioisotope; SPECT imaging; Rheumatoid arthritis; Macrophages; Glucocorticoids.

Spect Imaging of Tspo Expression in Rat Myocardial-Infarction-Reperfusion Models with Tc-99(M)-labeled Tspo Ligand Cb86

Preparation and Imaging of Arthritis of 99Tcm-Dtpa-cb86 for TSPO Targeted Imaging

Radiosynthesis and evaluation of acetamidobenzoxazolone based radioligand [C-11]N '-MPB for visualization of 18 kDa TSPO in brain

Assessment of TSPO in a Rat Experimental Autoimmune Myocarditis Model: A Comparison Study between [18F]Fluoromethyl-PBR28 and [18F]CB251

99Mtc-Labeled TSPO Ligand CB86 Targeting Macrophages for Rheumatoid Arthritis SPECT Imaging and Preliminary Evaluation of Anti-Inflammatory Effect

Radioiodinated Pentixather for SPECT Imaging of Expression of the Chemokine Receptor CXCR4 in Rat Myocardial-Infarction-Reperfusion Models

Experimental Study of [99mtc(pnp5) (DBODC)]+ As a New Myocardial Perfusion Imaging Agent.

[99mTc]-PentixaTec SPECT/CT for Imaging of Chemokine Receptor 4 Expression After Myocardial Infarction

Modelling [18F]LW223 PET data using simplified imaging protocols for quantification of TSPO expression in the rat heart and brain

[Myocardial Perfusion Imaging with [(99m)tc (N) (PNP5) (DBODC)](+) in Canine Model of Acute Myocardial Ischemia].

New 99mTc Radiotracers for Myocardial Perfusion Imaging by SPECT

In-LOOP Synthesis of 11C-Triphenylmethylphosphonium for Myocardial Perfusion Imaging

Preparation and Biodistribution of Myocardial Perfusion Imaging Agent ~(18)F-TPT

Translocator Protein (18 Kda): A Promising Therapeutic Target and Diagnostic Tool for Cardiovascular Diseases

Preclinical Evaluation of a Novel 99Mtc-Labeled CB86 for Rheumatoid Arthritis Imaging.

In Vivo Imaging of 99 M Tc-Glucarate-labeled Acute Necrotic Myocardium Using Microspect/ct

Evaluation of 99Mtcn-15C5 As a New Myocardial Perfusion Imaging Agent in Normal Dogs and Canines with Coronary Stenosis.

Experimental study of myocardial apoptosis with 99Tcm-FM2 imaging

Synthesis And Evaluation Of New F-18-Labelled Acetamidobenzoxazolone-Based Radioligands For Imaging Of The Translocator Protein (18 Kda, Tspo) In The Brain

Development of Novel 18F-Labeled PET Tracers for Imaging TSPO with Insensitivity to Rs6971 Polymorphism

Preclinical Evaluation of a Novel 99m Tc-Labeled CB86 for Rheumatoid Arthritis Imaging